Skinoren® 20% Cream is supplied by our pharmacy exclusively for the treatment of diagnosed moderate to severe acne vulgaris. If you have any other skin conditions, please consult your GP for an assessment and a prescription. If you already have a prescription, you can send it to us for dispensing.

Skinoren® Cream contains azelaic acid, which is effective in treating acne by reducing the formation of comedones (blackheads and whiteheads) and targeting acne-causing bacteria. This treatment helps alleviate symptoms and promotes clearer skin.

Why Choose Our PGD Service for Skinoren®?
Our PGD service allows for the direct supply of Skinoren® Cream to eligible patients without the need for a traditional prescription. This service is guided by strict protocols to ensure patient safety and the effectiveness of the treatment.

Who Can Benefit?
Skinoren® is recommended for individuals aged 12 to 64 with diagnosed moderate to severe acne vulgaris who do not want to consult their GP and prefer to access the treatment privately from our clinic.

Getting Started:
To access Skinoren® through our PGD service, start by completing our online consultation. Our team of healthcare professionals will review your information to determine if Skinoren® is the right choice for you.

What are the Service Inclusion Criteria?
Skinoren® is suitable for a specific group of individuals who meet the following criteria:

• Age Range: 12 to 64 years old.
• Acne Diagnosis: Individuals diagnosed with moderate to severe acne vulgaris.
• No Complicating Skin Conditions: Suitable for those whose acne is not complicated by other conditions like rosacea or perioral dermatitis.

What Will Happen Once I Have Answered the Questions in the Form?
A pharmacist trained to provide this private service will assess your form and may contact you to discuss the answers you provided.

Please Note:

• Access to your medical records or consent to contact your GP may be needed.
• As this is a treatment-specific product, we may need to identify you with an identity check (only for first-time buyers).
• Paying for this product will not guarantee its supply as the decision belongs to the pharmacist who will assess your eligibility based on your answers. All denied orders are refunded immediately.

Patient Information Leaflet.

• Active Ingredient: Azelaic acid (20% w/w)
• Excipients:
  • Benzoic acid (E210)
  • Cetearyl octanoate and isopropyl myristate (PCL Liquid)
  • Glycerol 85%
  • Glyceryl stearate, cetearyl alcohol, cetyl palmitate, and cocoglycerides (CUTINA CBS)
  • Propylene glycol
  • Purified water
  • Stearoyl macrogolglycerides

Skinoren® 20% Cream should be applied to the affected areas of the skin twice daily, once in the morning and once in the evening. For patients with sensitive skin, it is recommended to start with a single application in the evening for the first week. Before applying the cream, cleanse the skin with plain water or a mild cleanser and dry it thoroughly. A pea-sized amount should be applied and gently massaged into the skin. The duration of treatment varies, but noticeable improvement usually occurs within 4 weeks. For optimal results, the cream should be used continuously over several months but should not exceed 12 months of use.

• May cause skin irritation, particularly during the initial weeks of treatment. If irritation occurs, reduce the frequency of application.
  • Avoid excessive exposure to sunlight and use sunscreen with a high SPF (≥30) during treatment.
  • Not suitable for use with other topical acne treatments unless advised by a healthcare professional.

Contraindications

• Hypersensitivity to azelaic acid or any of the excipients listed.
  • Not suitable for use in patients under 12 or over 64 years of age.
  • Do not use if pregnant or breastfeeding.
  • Avoid use in patients with rosacea or perioral dermatitis.
  • Not recommended for patients with severe forms of acne, such as acne conglobata or acne fulminans.
  • Do not apply to sunburned skin or areas that have recently undergone chemical peels, laser treatments, or other dermatological procedures.
  • Avoid contact with eyes, mouth, and mucous membranes.

• Common Side Effects:
  • Burning sensation at the application site
  • Itching (pruritus)
  • Erythema (redness of the skin)
  • Dryness or peeling of the skin
• Uncommon Side Effects:
  • Seborrhea (excessive oiliness)
  • Acne exacerbation
  • Skin depigmentation
  • Contact dermatitis
  • Discomfort at the application site
• Rare Side Effects:
  • Cheilitis (inflammation of the lips)
  • Vesicles (small blisters)
  • Exacerbation of asthma

If you experience severe side effects or if symptoms persist, discontinue use and consult your GP or a healthcare professional. Report any adverse effects via the MHRA Yellow Card scheme.

For more information, please refer to the Patient Information Leaflet.